| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Expression profiling by array
|
CEL
|
Sep 29, 2010
|
|||||
| GSE24427 |
Expression data of multiple sclerosis patients receiving subcutaneous Interferon-beta-1b therapy [U133 A and B]
|
|
250 |
|
|
Robert Goertsches | Sep 29, 2010 | |
| GSE19657 |
Targeting resistance to Smoothened antagonists by inhibiting the PI3K pathway
|
|
27 |
|
John E Monahan | Sep 29, 2010 | ||
| GSE22005 |
Medulloblastoma tumors derived from Ptch+/-HIC+/- transgenic mouse allografted in nude mice
|
|
23 |
|
Michael Morrissey | Sep 29, 2010 | ||
| GSE22006 |
Medulloblastoma tumors derived from Ptch+/-p53-/- transgenic mouse allografted in nude mice
|
|
19 |
|
Michael Morrissey | Sep 29, 2010 | ||
| GSE22007 |
Targeting resistance to Smoothened antagonists by inhibiting the PI3K pathway
|
|
42 |
|
Michael Morrissey | Sep 29, 2010 | ||
| GSE24392 |
Lhx1 is required for specification of renal progenitor cell field
|
|
12 |
|
Hui Zhao | Sep 29, 2010 |
